Effect of Oxymetazoline Hydrochloride in Combination With Fluticasone Propionate on the Apnea Hypopnea Index (AHI) in Subject With Persistent Nasal Congestion and Mild Obstructive Sleep Apnea
Part of paid clinical trials in Tampa, Florida.
- Sponsor
- University of South Florida
- Study ID
- NCT02630121
- Phase
- PHASE4
- Status
- Recruiting
Conditions
- Chronic Nasal Congestion
- Sleep Apnea
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 65 Years
- Healthy Volunteers
- Not accepted
Interventions
- Oxymetazoline Hydrochloride — DRUGProportion of the subjects with 50% reduction in AHI.
- Placebo — DRUGProportion of the subjects with 50% reduction in AHI.
Study Details
The addition of intranasal oxymetazoline for two weeks to already instituted optimal doses of intranasal fluticasone propionate will decrease the total number of obstructive apneas and hypopneas per hour of sleep in subjects with perennial allergic or non-allergic rhinitis and mild obstructive sleep apnea who have persistent nasal congestion despite maximum doses of NGCS.
Key Dates
- Start date
- Apr 1, 2023
- Status verified
- Jan 2025
- Primary completion
- Apr 30, 2026
- Completion
- Apr 30, 2026
Study Design
- Enrollment
- 52 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- TREATMENT
Arms
- Placebo Comparator: Placebo/Fluticasone PropionatePlacebo Spray 2 Sprays QHS Fluticasone Propionate 1 spray BID
- Active Comparator: Oxymetazoline Hydrochloride /Fluticasone PropionateOxymetazoline Hydrochloride 2 Sprays QHS Fluticasone Propionate 1 spray BID
Primary Outcome Measure
The proportion of subjects demonstrating a 50% reduction in the apnea hypopnea index after treatment with oxymetazoline hydrochloride and fluticasone propionate for 2 weeks. [ Time Frame: 2 weeks ]
Central Contacts
- Catherine R Smith813-631-4024
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Usf Asthma Allergy and Immunology Cru | Tampa | Florida | 33613 | RICHARD F LOCKEY, MD (PRINCIPAL_INVESTIGATOR) DENNIS K LEDFORD, MD (SUB_INVESTIGATOR) ROGER W FOX, MD (SUB_INVESTIGATOR) MARK C GLAUM, MD (SUB_INVESTIGATOR) |
Find similar trials in Tampa, FL
By research site
Related Studies
- Personalized Obstructive Sleep Apnea Treatment and Effects on Alzheimer's Disease Biomarkers and Cognition Among BlacksRecruiting · University of Miami · Miami, Florida
- Sleep Apnea in ElderlyPHASE4 · Recruiting · VA Office of Research and Development · Detroit, Michigan
- Treatment of Sleep Apnea in Patients With Cervical Spinal Cord InjuryPHASE4 · Recruiting · John D. Dingell VA Medical Center · Detroit, Michigan
- Benefits of Oxytocin in Obstructive Sleep Apnea (OSA) Patients Using Continuous Positive Airway Pressure (CPAP) MachinePHASE1 · Recruiting · Vivek Jain · Washington D.C., District of Columbia